Document Detail


Pathologic caveolin-1 regulation of PTEN in idiopathic pulmonary fibrosis.
MedLine Citation:
PMID:  20395445     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Idiopathic pulmonary fibrosis (IPF) is a progressive fibroproliferative disorder refractory to current pharmacological therapies. Fibroblasts isolated from IPF patients display pathological activation of PI3K/Akt caused by low PTEN phosphatase activity. This enables these cells to escape the negative proliferative properties of polymerized collagen. The mechanism underlying low PTEN activity in IPF fibroblasts is unclear, but our prior studies indicate that membrane-associated PTEN expression is decreased in these cells. Caveolin-1 is an integral membrane protein whose expression is decreased in IPF lung tissue, but how low caveolin-1 contributes to pathological fibrosis is incompletely understood. The objective of this study was to examine the hypothesis that caveolin-1 regulates PTEN function in IPF fibroblasts. Here we demonstrate that caveolin-1 expression is a determinant of membrane PTEN levels and show that PTEN interacts with caveolin-1 via its caveolin-1-binding sequence. We demonstrate that caveolin-1 expression is low in IPF fibroblasts and that this correlates with low membrane PTEN levels, whereas overexpression of caveolin-1 restores membrane PTEN levels, inhibits Akt phosphorylation, and suppresses proliferation. We demonstrate that caveolin-1 and PTEN expression are low in myofibroblasts within IPF fibroblastic foci. These data indicate that IPF fibroblasts display low caveolin-1 expression, which results in low membrane-associated PTEN expression. This creates a membrane microenvironment depleted of inhibitory phosphatase activity, facilitating the aberrant activation PI3K/Akt and pathological proliferation.
Authors:
Hong Xia; Wajahat Khalil; Judy Kahm; Jose Jessurun; Jill Kleidon; Craig A Henke
Related Documents :
16179375 - The inositol phosphatase ship-2 down-regulates fcgammar-mediated phagocytosis in murine...
10851265 - Expression of pten and pten pseudogene in endometrial carcinoma.
22747515 - Quantitative expression analysis of the apoptosis-related gene, bcl2l12, in head and ne...
16231315 - Expression of a thioredoxin-related protein-1 is induced by prostaglandin e(2).
16675515 - Effect of developmental exposure to chlorpyrifos on the expression of neurotrophin grow...
22126455 - Renal microvascular injury in chronic aristolochic acid nephropathy and protective effe...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2010-04-15
Journal Detail:
Title:  The American journal of pathology     Volume:  176     ISSN:  1525-2191     ISO Abbreviation:  Am. J. Pathol.     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-06-03     Completed Date:  2010-10-04     Revised Date:  2014-09-08    
Medline Journal Info:
Nlm Unique ID:  0370502     Medline TA:  Am J Pathol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2626-37     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Apoptosis / physiology
Caveolin 1 / genetics,  metabolism*
Cell Line
Cell Membrane / metabolism
Collagen / metabolism
Fibroblasts / cytology,  metabolism
Humans
Idiopathic Pulmonary Fibrosis / metabolism*
PTEN Phosphohydrolase / genetics,  metabolism*
Proto-Oncogene Proteins c-akt / metabolism
Grant Support
ID/Acronym/Agency:
P01 HL091775/HL/NHLBI NIH HHS; P01 HL091775-026586/HL/NHLBI NIH HHS; P01 HL91775/HL/NHLBI NIH HHS; R01 HL074882/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Caveolin 1; 9007-34-5/Collagen; EC 2.7.11.1/Proto-Oncogene Proteins c-akt; EC 3.1.3.48/PTEN protein, human; EC 3.1.3.67/PTEN Phosphohydrolase
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outco...
Next Document:  Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma ...